Literature DB >> 34313175

Between a rock and a hard place: COVID-19 vaccination and patients on rituximab therapy.

Benjamin W Teh1,2,3, Constantine S Tam4,5.   

Abstract

Entities:  

Year:  2021        PMID： 34313175     DOI： 10.1080/10428194.2021.1957879

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  3 in total

1.  Patient and health practitioner views and experiences of a cancer trial before and during COVID-19: qualitative study.

Authors:  Frances C Sherratt; Peter Fisher; Amy Mathieson; Mary G Cherry; Andrew R Pettitt; Bridget Young
Journal:  Trials       Date:  2022-06-18       Impact factor: 2.728

2.  Low levels of anti-SARS-CoV-2 antibodies after vaccination in rituximab-treated patients: comment on the article by Simon et al.

Authors:  Gerasimos Evangelatos; Konstantina Kouna; George E Fragoulis; Melina Moschopoulou; Maria Triantafylli; Antigoni Lekka; Alexios Iliopoulos
Journal:  Arthritis Rheumatol       Date:  2022-04-05       Impact factor: 15.483

3.  Is BTKi or BCL2i preferable as first novel therapy in patients with CLL? The case for BCL2i.

Authors:  John F Seymour
Journal:  Blood Adv       Date:  2022-02-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.